FDA OKs Merck drug to stop infection post-stem cell transplant – Reuters
|
FDA OKs Merck drug to stop infection post-stem cell transplant
Reuters Nov 9 (Reuters) – Merck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug Administration, the drugmaker said on Thursday. The drug was approved to prevent … |
